PlatformQ Health celebrates a busy end to 2020 with 15 digital programs in the month of December, including both accredited online healthcare provider activities and patient education sessions. These programs were produced in collaboration with some of the leading aligned professional organizations, centers of excellence and patient advocacy groups. Each program is available on one or more of our therapeutically aligned learning channels that are designed to meet the specific needs of patients, caregivers, and clinicians.

Therapeutic area spotlight

We deliver our education across the therapeutic spectrum through specialty websites, allowing clinicians, patients, and caregivers to receive information most relevant to them. Over the month of December, we produced expert-led digital educational content in Oncology, Urology, Psychiatry, Diabetes, and Neurology. The following learning channels were especially active within the last month:

Partner spotlight

Our partnerships enable us to create libraries of innovative digital education that improves health outcomes and quality of care.  Some of our recent program from December have been developed and disseminated with the following key partners:

  • Solving Kid’s Cancer
  • LUGPA
  • The Atlanta School of Sleep Medicine & Technology
  • Joslin Diabetes Center

Start watching on-demand today

Management of High-Risk Relapsed/Refractory Pediatric Neuroblastoma Novel Agents and Patient Perspectives for Advanced Practitioners

In this accredited CME activity, produced in collaboration with Solving Kid’s Cancer, top experts discuss the latest medical science on high-risk relapsed/refractory pediatric neuroblastoma. They address the mechanisms of action of emerging agents for relapsed/refractory high-risk neuroblastoma, strategies to manage challenges of administration and treatment-related adverse effects, and how to best facilitate communication with patients, caregivers, and families in navigating treatment options, side-effect management and care coordination.  It is currently available to stream at any time on OMedLive and CancerCoachLive until December 4th, 2021. Participants can earn 1 AMA PRA Category 1 Credit™.

Featured Speakers:

  • Shakeel Modak, MD, Acting Chief, Neuroblastoma Service, Attending, Pediatrics, Memorial Sloan Kettering Cancer Center
  • Rachel Glincher, RN, MSN, CPNP-AC, CPHON, Pediatric Nurse Practitioner, Memorial Sloan Kettering Cancer Center
  • Donna Ludwinski, Director of Research Advocacy, Solving Kids’ Cancer
  • Gregory Sizikov, Parent Panelist

Resolving Unmet Treatment and Quality-of-Life Needs of Patients with Recurrent Endometrial Cancer

Clinicians are invited to earn 1 AMA PRA Category 1 Credit™ in this 60-minute, expert-led presentation evaluating the relevance of histology and molecular testing to facilitate treatment decision-making, assessing the clinical-trial evidence of new and practice-changing therapies for the management of recurrent endometrial cancer, and discussing strategies to monitor and manage treatment-emergent adverse events associated with current and emerging regimens. The panelists also take the time to discuss how to best facilitate conversations between patients and providers to improve long-term quality of life. This program is currently available on OMedLive until December 5th, 2021.

Featured Speaker:

  • Paul A. DiSilvestro, MD, Professor, Department of Obstetrics and Gynecology, Director, Program in Women’s Oncology and Division of Gynecologic Oncology, Women, and Infants Hospital of RI

Addressing Real-World Challenges of Integrating Novel Therapies for Patients with Upper Tract Urothelial Carcinoma

Dr. Neal Shore leads the second session of this 2-part program on Upper Tract Urothelial Carcinoma, produced in collaboration with LUGPA, available on both UroCareLive and OMedLive. Participants can earn 1 AMA PRA Category 1 Credit™ while learning how to assess barriers and challenges to a shifting clinical landscape for UTUC. Hear from experts on real-world data, current and emerging evidence for risk-based treatment approaches and facilitate team-based strategies to improve timely, safe, and effective clinical integration of novel treatment approaches. This session will be available to watch at anytime on-demand until December 8th, 2021.

Featured Speakers:

  • Neal D. Shore, MD, FACS, Medical Director, CPI, Carolina Urologic Research Center, Atlantic Urology Clinics
  • Phillip M. Pierorazio, MD, Associate Professor of Urology and Oncology, Brady Urological Institute and Department of Urology, Johns Hopkins University

Managing Insomnia: Guidelines, Evidence, Safety and What Matters to Patients and Their Families

We collaborated with The Atlanta School of Sleep Medicine to produce a 60-minute virtual presentation that provides clinicians the latest on understanding the impact of insomnia on the performance, relationships and psychological behaviors of individuals and other members of the household and recommendations for the management of insomnia. Additionally, the expert panel discussed the limitations and safety concerns of medications traditionally used to treat insomnia, and new treatment approaches that target the orexin pathways and align with patient expectations and management goals. Participants can watch this program on-demand on ClinicalSeriesLive and PsychiatryCareLive until December 8th, 2021 and can earn 1 AMA PRA Category 1 Credit™.

Featured Speakers:

  • Russell Rosenberg, MD, Founder and Director, Atlanta School of Sleep Medicine and Technology
  • Maha Ahmad, MD, MMSc, Medical Director, Sleep Disorders Institute and Clinilabs Drug Development Corporation
  • Paul Doghramji, MD, Senior Family Practice Physician, Collegeville Family Practice

This program followed the tethered education model: an educational program on new therapeutic approaches for insomnia for patients and caregivers took place live on November 24. The program was produced in collaboration with the American Sleep Association. During the CME activity, the faculty panel comments on several key findings from the patient program, Insomnia, Do Not Lose Sleep Over It and Work With Your Doctor! 

2020 LUGPA Crossfire Series: Private Equity (PE): Fad or Future?

LUGPA has been a key partner in 2020, collaborating with us to produce nearly a dozen virtual presentations in the LUGPA Virtual Crossfire Series. The LUGPA Virtual Crossfire Series has covered clinical and practice topics along with administrative and management matters important to LUGPA members. The expert panelists engage in a discussion on private equity that aims to provide value to clinicians and their practice. This program aired live giving the audience the opportunity to submit questions and have them discussed by the expert panelists during the event. This 60-minute presentation is available on UroCareLive until December 9th, 2021.

Featured Speakers:

  • Neal D. Shore, MD, FACS, Medical Director, CPI, Carolina Urologic Research Center, Atlantic Urology Clinics
  • Scot Davis, CEO, Arkansas Urology
  • Jonathan Henderson, MD, LUGPA President, CEO, Regional Urology, LLC
  • Deepak A. Kapoor, MD, Market President, Integrated Medical Professionals, Chairman and Chief Ecosystem Officer, Solaris Health Holdings, LLC, Clinical Professor of Urology, The Icahn School of Medicine at Mount Sinai

2nd Annual Virtual Summit: Optimizing Uro-Oncology Care for Patients with Metastatic and Nonmetastatic Prostate Cancer

In collaboration with LUGPA, we launched the 2nd Annual Virtual Summit on UroCareLive, with 4 consecutive expert-led digital education sessions about optimizing uro-oncology care for patients with metastatic and non-metastatic prostate cancer from utilizing biomarkers to new therapies. The following sessions from the summit are available to watch on-demand until December 14th, 2021 and participants can earn 3 AMA PRA Category 1 Credit™:

  • Session One: Utilizing Biomarkers to Navigate Treatment Decisions for Prostate Cancer Patients
  • Session Two: Integrating New Therapies in the Management of Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC)
  • Session Three: Optimizing Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Session Four: PARP Inhibition: A New Paradigm in Prostate Cancer Care

Featured Speakers:

  • Neal D. Shore MD, FACS, Medical Director, CPI , Carolina Urologic Research Center, Atlantic Urology Clinics
  • Oliver Sartor MD, Professor of Medicine, Medical Director, Tulane Cancer Center; C. E. and Bernadine Laborde Professor of Cancer Research, New Orleans, LA
  • Tomasz M. Beer, MD, FACP, Grover C. Bagby Endowed Chair for Prostate Cancer Research, Deputy Director, OHSU Knight Cancer Institute, Chief Medical Officer, CEDAR, Professor of Medicine, Hematology & Medical Oncology, Director, Prostate Cancer Research Program, Oregon Health & Science University, Portland, Oregon
  • Simpa S. Salami MD, MPH, Assistant Professor of Urology, Division of Urologic Oncology, Department of Urology, University of Michigan, Ann Arbor, Michigan
  • David I. Quinn MD, Associate Professor of Medicine (Clinical Scholar), Section Head, Genitourinary (GU) Oncology, Division of Cancer Medicine and Blood Diseases in the Department of Medicine, Health Sciences Campus, Los Angeles, CA

LUGPA Virtual Crossfire Series: A case-based discussion: Use of genomic testing in patients with low and favorable intermediate risk prostate cancer

The final session of the 2020 LUGPA Virtual Crossfire Series aired on December 16th and will be available to watch on UroCareLive for 6 months. This session includes a series of cases that the expert panel will address with a focus on the use of genomic testing in patients with low and favorable intermediate risk prostate cancer. Participants will be given the chance to elarn how to review NCCN guidelines around genomic testing, understand the important of assessing risk of adverse pathology when active surveillance is being considered, and more. Check out this program and the rest of the LUGP Virtual Crossfire Series on-demand today.

Featured Speakers:

  • Neal D. Shore, MD, FACS, Medical Director, CPI, Carolina Urologic Research Center, Atlantic Urology Clinics
  • Brian T. Helfand, MD, PhD, Northshore University Health System, University of Chicago
  • Steven Canfield, MD, Chief of Urology, Memorial Hermann-Texas Medical Center, Bard/McQuire Distinguished Chair in Urology, McGovern Medical School at UTHealth

Reaching and Achieving Patient-Desired Treatment Outcomes in Major Depressive Disorder: Multiple Approaches Suggest Better Outcomes

This program follows the tethered education model; created to help fill communication gaps between patients and clinicians on major depressive disorder care. In this session, clinicians learn how to better identify barriers to achieving patient-desired outcomes, summarize multiple therapeutic approaches in treating patients with depressive symptoms despite antidepressant therapy, and evaluate new and evolving treatment strategies for people with MDD. They also learn strategies for improved shared decision making and treatment goals while given the opportunity to earn AMA PRA Category 1 Credit™. This session will be available on PsychiatryCareLive until December 18th, 2021.

Featured Speakers:

  • Michael E. Thase, MD, Professor of Psychiatry, Perelman School of Medicine, University of Pennsylvania
  • Larry Culpepper, MD, Professor of Family Medicine, Boston University School of Medicine

Changing the Treatment Paradigm in Schizophrenia: Customizing Antipsychotic Approach to Match Patient Needs

This program was produced to help clinicians determine transitioning strategies between antipsychotic formulations in patients with schizophrenia, identify clinical and physiological consequences of nonadherence and treatment discontinuation of antipsychotic therapy and strategies to address such issues. It incudes 2 patient vignettes in which patients share their experiences with schizophrenia to provide clinicians perspective on their needs and treatment goals. This program features an interview from a representative from the Schizophrenia and Related Disorders Alliance of America (SARDAA), sharing available support tools for people with schizophrenia and their families. This session is available to watch on PsychiatryCareLive on-demand until December 23rd, 2021. Participants can learn alongside top experts and earn AMA PRA Category 1 Credit™.

Featured Speaker:

  • Charles B. Nemeroff, MD, PhD, Matthew P. Nemeroff Professor and Chair, Department of Psychiatry and Behavioral Sciences, Mulva Clinic for the Neurosciences, Director, Institute of Early Life Adversity Research, Dell Medical School, The University of Texas at Austin

Digital Technologies and Insulin Therapy: Evolving Paradigms for Digital Tools and Methods

In collaboration with Joslin Diabetes Center, this tethered education program was developed to improve health outcomes in diabetes with the use of technology such as smart pen pump and continuous glucose monitoring system. The clinician education program on DiabetesSeriesLive is broken up into 3 sessions, Technology Today: Breaking News on the Devices for Diabetes, Technology and Telemedicine: Perspectives for Diabetes Care and Technology and the Patient: Shared Decision-Making Made Easy. Three downloadable PDF, each focusing on the characteristics of pen, CGM and pump respectively are available to download to clinicians into shared decision-making when recommending a pen, a CGM or a pump to a patient. This very lively discussion will feature a stellar faculty panel including:

During these sessions, participants can get the latest medical science and earn AMA PRA Category 1 Credit™. This program will be available on DiabetesSeriesLive.

Featured Speakers:

  • Richard Beaser, MD, Associate Professor of Medicine, Harvard Medical School, Joslin Diabetes Center
  • Diana Isaacs, PharmD, BCPS, BC-ADM-BCAP, CDCES,Clinical Pharmacy Specialist, Co-Director, Center of Excellence for Endocrine Disorders in Pregnancy, CGM Program Coordinator, Cleveland Clinic Endocrinology & Metabolism Institute Diabetes Center

Digital Technologies and Insulin Therapy: Could These Help Me Manage My Diabetes?

The tethered patient education session is part of the education programming on diabetes care, produced in collaboration with the Joslin Diabetes Center. The program is broken up into 4 short chapters, Chapter 1: What is new in digital technology to help me use insulin to treat my diabetes?, Chapter 2: What are insulin smart pens and could they be useful to me?, Chapter 3: Could continuous glucose monitoring be right for me?, and Chapter 4: Pumps: What do they do, and should I consider one?. The faculty, which will include a person with diabetes, prioritizes dialog and exchange about the place of diabetes technology in 2021 diabetes care, and shares strategies to address questions from patients when discussing whether a pump, a pen or a CGM is an option for care. Three downloadable PDF, each focusing on the characteristics of pen, CGM and pump respectively are available to download to guide patients into their shared decision-making process. Patients and caregivers can watch this program at any time on-demand on DiabetesCoachLive.

Featured Speakers:

  • Richard Beaser, MD, Associate Professor of Medicine, Harvard Medical School, Joslin Diabetes Center
  • Diana Isaacs, PharmD, BCPS, BC-ADM-BCAP, CDCES,Clinical Pharmacy Specialist, Co-Director, Center of Excellence for Endocrine Disorders in Pregnancy, CGM Program Coordinator, Cleveland Clinic Endocrinology & Metabolism Institute Diabetes Center
  • Anne Peters, MD, CDE, Professor of Medicine, Keck School of Medicine of USC (University of Southern California)
  • Mary Paschal, RN, MS, CDE, Beth Israel Deaconess Hospital Needham

Have questions about this educational series or want to learn more about how PlatformQ Health is delivering impactful education to HCPs and patients? Email us at digital@platformq.com. 

PlatformQ Health partners with leading health care experts and patient advocacy organizations to produce digital education – including tethered programming – across a range of health topics.

 

Post navigation